Advent France Biotechnology
Advent France Biotechnology (AdBio partners) is a venture capital firm based in Paris, France and Barcelona, Spain. Specializing in early-stage investments, the firm was established to support life sciences startups across Europe. AdBio partners emphasizes a strong entrepreneurial spirit in their investments. Their team is composed of industry experts with extensive backgrounds in biotechnology and healthcare, which differentiates them by providing valuable insights and support for their portfolio companies.
AdBio partners focuses exclusively on the life sciences sector, with a particular interest in biotechnology and healthtech startups. They invest at the early stages, predominantly in Europe, aiding startups to develop their cutting-edge technologies quickly. Their notable fund, AFB Seed-Fund I, is backed by InnovFin Equity and the European Union under the Horizon 2020 Financial Instruments, aiming to enhance investment in productive sectors across Europe.
Notable investments in AdBio partners' portfolio include companies like SparingVision, Tenpoint Therapeutics, and Agomab, which are advancing in areas such as gene therapy, regenerative medicine, and novel therapeutics. They partner with companies spearheading new discoveries in healthcare and support their growth with both strategic insight and capital.
Advent International
Advent is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses.
Since our founding in 1984, we have developed specialist market expertise across our five core sectors: business & financial services, consumer, healthcare, industrial, and technology.
As one of the largest privately-owned partnerships, our 600+ colleagues across five continents leverage the full ecosystem of Advent’s global resources to support and guide our portfolio companies as they seek to achieve their strategic goals.
To learn more, visit adventinternational.com.
Advent Life Sciences
Advent Life Sciences is a venture capital firm based in London, founded in 2006. The firm specializes in life sciences investments with a focus on building innovative businesses in the UK, Europe, and the USA. The team comprises experienced entrepreneurs and investors who have a strong track record in turning breakthrough science into approved medicines and medical products. This hands-on team supports portfolio companies closely and aligns with management teams to realize their visions.
Advent Life Sciences invests in early and mid-stage companies, with particular interest in new drug discovery, med tech, enabling technologies, and vaccines. The firm focuses on seed and Series A stages with a geographical interest in trans-Atlantic opportunities. Advent's portfolio boasts companies that have brought 15 innovative medicines and products to market since its inception.
Notable investments include Pheno Therapeutics - multiple sclerosis therapies, F2G - antifungal treatments, Amphista Therapeutics - cancer treatments, and other leading edge life sciences companies. These significant investments reflect the firm's strength in identifying and supporting high-potential ventures in the life sciences sector.
Advent Morro Equity Partners
Advent Morro Equity Partners is a private equity firm headquartered in San Juan, Puerto Rico, established in 1989. Led by Managing Partner Cyril Meduña, the firm's team includes key figures such as Principal Allison Kern and Senior Associate José Tomás Echeverría. With over three decades of experience, Advent Morro has distinguished itself as one of the region’s leading investment firms by focusing on growth and equity value creation across various sectors, making a significant impact on Puerto Rico’s economy.
Advent Morro invests in a diverse range of industries, including healthcare, telecommunications, distribution, technology services, education, and hospitality. The firm primarily operates within Puerto Rico, supported by its historical connection with Advent International Corporation from 1997 to 2010. The average investment size is around $7 million, with a robust portfolio generating over $3.5 billion in yearly sales.
Notable investments include companies in the healthcare and technology sectors, reflecting their strategic focus on high-growth industries. Although specific portfolio companies aren't listed, the firm's successful track record is evident through over 50 investments since its inception.
Advent Partners
Advent Partners is a growth-focused private equity firm based in Melbourne, Australia. Founded over 40 years ago, it is one of Australia’s longest-standing investment managers with a focus on partnering with founders and entrepreneurs to scale market-leading companies. The firm differentiates itself by emphasizing a hands-on, partnership-driven approach and a commitment to responsible investing, with a team that actively collaborates with management to accelerate growth.
Advent Partners invests across a range of sectors, including healthcare services, education, consumer products, and industrials, typically targeting investments with strong growth potential. The firm manages over $1 billion in assets under management through eight funds. Its investor base includes large superannuation funds, sovereign pension funds, and international endowment funds. They follow a responsible investing framework that aligns with ESG standards.
Notable companies in Advent Partners’ portfolio include Very Special Kids - providing hospice care for children with life-threatening conditions, FareShare Australia - fighting hunger by rescuing surplus food, and several other market-leading companies in various stages of growth.
Advent Venture Partners
Advent Venture Partners was a venture capital firm based in London, United Kingdom, founded in 1981. The firm specialized in investing in early and mid-stage companies across the United Kingdom, Europe, and the United States. Advent Venture Partners focused on sectors such as information technology, healthcare, drug discovery and development, diagnostics, manufacturing, media, retail, and mobile. The firm was known for its strategic approach to building partnerships with entrepreneurs to create valuable businesses.
Advent Venture Partners invested in a variety of sectors including enterprise applications and consumer products. The firm targeted early revenue stages and had a portfolio that included companies in the United Kingdom and the United States. Over its operational years, Advent Venture Partners made 151 investments and achieved 91 exits. The firm was recognized for its contributions to the growth of market-leading tech and life sciences businesses.
Notable investments by Advent Venture Partners included Moximed - therapeutic devices, Spigraph - IT consulting and outsourcing, Worldstores - internet retail, The Transaction Auditing Group - other financial services, and Contura International - medical supplies. The firm also invested in Orphalan - biotechnology, Seal Software - business/productivity software, and Farfetch - internet retail.
Adventure Capital
Adventure Capital Private is a leading Australian early-stage technology venture investor, at the epicentre of the ecosystem and passionate about advancing local human and intellectual capital, and enabling global opportunities for driven entrepreneurs and their businesses to reach their full potential.
Adventure Capital Private is sourcing and funding the significant opportunities arising from the rapid growth of early-stage technology businesses - leveraging our experience and active involvement in driving capital efficient, globally focussed businesses.
Adventure Capital Private is a super-angel style venture investor focused on finding and guiding early-stage tech companies that are highly capital efficient and have global ambition and scope. The investment approach is active and startups benefit from the experience the team has in rapid early-stage growth and exits, leveraging the strong ecosystem built around the team both in Australia and internationally.
AE Industrial Partners, LP
AE Industrial Partners, LP is a private equity firm based in Boca Raton, Florida, founded with a focus on technologies and services critical to national and economic security. The firm is supported by a team of over 117 professionals with deep industry knowledge and experience in investment, operations, and technical fields. Their approach is characterized by a strong partnership ethos and a commitment to integrity and trust. AE Industrial Partners is distinguished by its thematic and growth-oriented investment strategy, balancing organic and acquisition-based growth initiatives to drive long-term value creation.
AE Industrial Partners invests primarily in the aerospace, defense, and industrial sectors. They focus on companies with differentiated capabilities that benefit from their investment track record. The firm typically participates in venture capital, private equity, and aircraft leasing investments, with a substantial asset base of $9.4 billion under management. Their investments are often oriented towards North American markets but extend globally due to the nature of their focus sectors.
Notable portfolio companies include Blue Raven Solutions, a technology-enabled distribution platform in defense; Sierra Space, specializing in space exploration technologies; BigBear.ai, which focuses on artificial intelligence solutions; Gryphon Technologies, offering engineering services; and Firefly Aerospace, a developer of orbital launch vehicles.
AEA Investors
AEA Investors is a global private equity firm based in New York City, established in 1968 by prominent industrial families including the Rockefeller, Mellon, and Harriman interests as well as S.G. Warburg & Co. With a team of over 110 investment professionals across seven offices worldwide, AEA is known for its long-term investment approach and its highly collaborative culture. The firm prides itself on its strong global network and its deep industry expertise, which it leverages to support and grow businesses across a wide range of sectors.
AEA Investors focuses primarily on private equity, growth equity, and private debt solutions. Its sector focus includes industrial sectors such as business services, consumer products, healthcare, and technology. AEA provides tailored investment solutions through its various platforms, including Middle Market, Enterprise, and Elevate. The firm manages approximately $19 billion in assets.
Notable investments from AEA Investors include companies like 1-800 Contacts - a contact lens supplier, Jack's Family Restaurants - a regional restaurant chain, and Traeger Grills - known for its wood pellet grills. The firm has a history of successful partnerships with portfolio companies, helping them achieve sustainable long-term growth.
Aemstel Ventures BV
Aemstel Ventures is a private equity boutique based in Amsterdam, founded by seasoned entrepreneurs Bart Voorvaart and Thomas Kasha. With backgrounds in investment banking, law, and entrepreneurship, the team brings a wealth of experience to complex business renewal challenges. Aemstel Ventures focuses on sustainable innovations, operating with a pragmatic approach to unlock shareholder value. They leverage their strategic network of banks and financial institutions for capital needs, and are known for their hands-on, creative problem-solving methods. The firm is committed to building long-term partnerships with stakeholders.
Aemstel Ventures invests in a wide array of sectors, highlighting sustainable disposables, engineering, and software development as areas of expertise. They are not limited to specific industries, which allows them flexibility in investment. The firm engages with enterprises that require risk-bearing capital for product development and market expansion. Their entrepreneurial drive aids swift and decisive intervention in business renewal processes. There is no specific information about the total assets under management or specific fund details available.
In their investment portfolio, Aemstel Ventures has supported various companies dealing with product development and sustainability. While exact company names are not disclosed, their focus remains on ventures needing strategic development and financial solutions to achieve growth. The firm's relationships with businesses hinge on enduring solutions and sustainable innovations, ensuring a positive impact within their investment sphere.